Trusted medical support in China for Mongolian patients
Cross-border care assistance · Standard service
China–Mongolia cross-border medical consultation is available. Contact us by phone or Facebook.Partner of the Third Central Hospital of Mongolia
Back to doctors
Chen Yue
Physician

China-Japan Friendship Hospital · Pharmacy Department · Beijing

ICU,

《 》、《 》、《 》.: 2007/09–2012/07:,,, 2003/09–2007/07:,,.: 2021/09 –:, 2014/08 – 2021/08:,: SCI,. 《 (2021 )》、《 》.,,.: 1.ChenY,LiuL.Thetreatmentofnosocomialmeningitisandbrainabscessbycarbapenem-resistantKlebsiellapneumonia.BrJNeurosurg.2023Aug;37(4):634-636.doi:10.1080/02688697.2018.1530729.Epub2019Jul25.PMID:31342790. 2.ChenY,LiuL,ZhuM.Intraventricularadministrationofantibioticsbyommayareservoirforpatientswithmultidrug-resistantAcinetobacterbaumanniicentralnervoussysteminfection.BrJNeurosurg.2021Apr;35(2):170-173.doi:10.1080/02688697.2020.1777255.Epub2020Jul13.PMID:32657168. 3.ChenY,XiangQ,LiuL.Comparisonofantibiotic-associateddiarrheacausedbycefoperazone/sulbactamorpiperacillin/tazobactaminneurosurgerypatients.JIntMedRes.2021May;49(5):3000605211019661.doi:10.1177/03000605211019661.PMID:34057835;PMCID:PMC8170296. 4.ChenY,LiF,ZhuM,LiuL,LuoY.Outcomeandfactorsofpatientswithnosocomialmeningitisbymulti-drug-resistantGram-negativebacteriainatertiaryhospitalinChina:aretrospectivestudy.BrJNeurosurg.2020Jun;34(3):324-328.doi:10.1080/02688697.2019.1710819.Epub2020Feb7.PMID:32031020. 5.ChenY,LiuL,ZhuM.Effectofaugmentedrenalclearanceonthetherapeuticdrugmonitoringofvancomycininpatientsafterneurosurgery.JIntMedRes.2020Oct;48(10):300060520949076.doi:10.1177/0300060520949076.PMID:33100081;PMCID:PMC7604945. 6.,,. [J].,2023,23(10):910-913. 7.,,. / [J].,2023,23(08):913-916.DOI:10.14009/j.issn.1672-2124.2023.08.004 8.,,. [J].,2022,20(10):83-86. 9.,. [J].,2022,31(08):606-610.DOI:10.19577/j.1007-4406.2022.08.009 10.,,. [J].,2022,20(04):89-92. 11.,,. [J].,2022,20(02):67-75. 12.,,. [J].,2021,19(04):34-38. 13.,,. / [J].,2021,30(01):46-50.DOI:10.19577/j.1007-4406.2021.01.012 14.,,. [J].,2021,19(01):68-71. 15.,,. 1 [J].,2021,19(01):81-83. 16.,,. [J].,2020,18(09):53-57. 17.,,. [J].,2020,43(06):1142-1146. 18.,,. [J].,2020,17(02):160-163. 19.,,. [J].,2019,23(11):2312-2315. 20.,,. [J].,2019,16(04):239-242. 21.,,. 1 [J].,2019,23(08):1617-1620. 22.,,. B [J].,2019,16(03):161-164. 23.,,. CYP2C19 [J].,2019,16(02):63-66. 24.,,. [J].,2019,38(03):392-395. 25.,,. [J].,2018,15(05):295-297+318. 26.,,. [J].,2018,16(06):75-77. 27.,.Ommaya [J].,2018,28(15):120-123. 28.,,. [J].,2018,53(07):565-568. 29.,,. [J].,2018,16(03):81-85. 30.,. [J].,2018,37(01):50-53. 31..1 [J].,2017,21(09):1728-1730. 32.,.1 ICU [J].,2017,15(08):78-81. 33.. -6 [J].,2017,36(06):646-649.,,. [J].,2016,13(01):36-39.: ICU 2,.: 2020

Remove this favorite?